Calpains are a family of related proteins, originally classi®ed on the basis of their calcium dependence and protease activity. Here we report the mRNA expression patterns during mouse development of the recently identi®ed Capn5, Capn6 and Capn11 genes. The major expression sites of Capn5 during embryogenesis are the developing thymus, sympathetic and dorsal root ganglia. Capn6 mRNA is exclusively expressed during embryogenesis predominantly in developing skeletal and heart muscle overlapping closely with Capn3 expression domains. Expression was also observed in speci®c cells of the lung, kidney and placenta and in various epithelial cell types where the Capn6 mRNA appeared to be localized within the cell to the basal and apical ends. Capn11 mRNA is restricted exclusively to spermatocytes and only during the later stages of meiosis. q
Introduction
Recently, four novel calpain genes Capn5, Capn6, Capn7 and Capn11, were reported (Dear et al., 1997 Franz et al., 1999) . With the discovery of these genes, the calpains can be divided into four subclasses based on sequence homology, predicted protease activity and calcium dependence. Class A comprises the`traditional' calpains which are Ca 21 -dependent (CAPN1, CAPN2, CAPN3, CAPN11), classes B and D calpain-like proteins may be Ca 21 -independent (CAPN5 and CAPN7, respectively) while the class C calpain-like protein (CAPN6) may lack protease activity. The expression domains in the mouse of these new calpains were investigated by RNA ®lter and in situ hybridization analysis.
Initially, expression of Capn5, Capn6, Capn7 and Capn11 mRNAs were examined by hybridization of 32 Plabeled cDNA probes to an RNA dot blot containing various mouse tissues (Fig. 1) . Capn7 mRNA appeared to be ubiquitously expressed at similar levels in all tissues and was not investigated further. Hybridization signals for the other three calpains exhibited variability on the blot; thus there expression patterns were further analyzed by in situ hybridization.
Expression of Capn5 mRNA during embryogenesis
Capn5 mRNA was expressed widely in the adult mouse albeit at varying levels ( Fig. 1) . In situ hybridization in day 16.5 embryos revealed a generally low level of expression. However, several tissues expressed much higher levels of Capn5 mRNA. The developing thymus was the major site of Capn5 mRNA in the embryo (Fig. 2A±D ). Sections from embryos aged 12.5, 14.5 and 16.5 were hybridized with probes for Capn5, Whn and CD3e. Whn mRNA is a marker the epithelial cells of the developing thymus (Nehls et al., 1996) while CD3e mRNA is speci®c for T cell precursors in the thymic tissue (Clevers et al., 1988) . T cell precursors start to migrate into the thymus at approximately dE13.5 and thus any expression in the thymus anlage prior to this stage likely re¯ects expression in the epithelial component. As shown in Fig. 3 , Capn5 mRNA is not present in the Whnexpressing thymus anlage at dE12.5 but its expression correlates with the that of CD3e at dE14.5 and dE16.5 suggesting that the high Capn5 mRNA expression observed in the thymus anlage is restricted to the T cell precursors. Elevated levels of Capn5 mRNA were also evident in the neurons of the sympathetic (Fig. 2E±G, Fig. 3 ) and the dorsal root ganglia ( Fig. 2A,B,G) .
Expression of Capn6 mRNA
Previously, CAPN6 mRNA expression was only observed in the placenta of 50 human tissues tested (Dear et al., 1997) with no expression in any of the adult tissues on the blot. Northern dot blot analysis of adult mouse tissue poly(A 1 ) RNAs revealed a similar lack of Capn6 expression with the exception of very weak signals in the thyroid and testis. However, Capn6 mRNA was expressed strongly in RNA from embryo days 7, 11, 15 and 17 (Fig. 1 ). This expression was further investigated by in situ hybridization to embryos and placenta. Expression in the placenta was much weaker than that in the embryo and found only in the chorionic plate, the fetal border of the placenta which consists of extra-embryonic mesodermal cells (Fig. 4A±C) . The hybridization signal for Capn6 mRNA in the embryo proper was extraordinarily strong, at least 20 times higher than that for any other calpain mRNA (data not shown). At dE11.5 and dE12.5, strong hybridization signals for Capn6 mRNA were seen in the somites (Fig. 4F,G) , the mandibular component of the ®rst branchial arch (the future tongue) and in the developing heart muscle (Fig. 4I,J) . The epithelium of the developing tongue expressed higher levels than the mesenchyme. Surprisingly, hybridization was localized to two tracks running along the apical and basal borders of the epithelium (Fig. 4K,L) . This was a characteristic feature of 32 P-labeled DNA probes corresponding to segments of the indicated mouse cDNAs were sequentially hybridized to a Clontech Mouse Master Blot, a nylon ®lter containing dot-blotted poly(A)
1 RNAs from various mouse tissues. The location of the RNAs on the dot blot ®lter is indicated on the bottom right. The blot was rehybridized with a Hprt DNA probe to con®rm RNA loading. Exposure times were 48 h for all probes.
epithelial expression as a similar pattern was seen in the epithelium bordering the fourth ventricle (Fig. 4M,N) and that of the developing lobar bronchi ( Fig. 4O,P) . The suggests an unequal distribution of Capn6 RNA in the cytosol of these cells. The signi®cance of this is unclear; RNA localization within epithelial cells has been previously reported and it has been hypothesized that this may be a mechanism for protein targeting within developing or differentiating cells (Kislaukis and Singer, 1992) .
The lung bud expressed Capn6 mRNA in two distinct regions, the epithelium of the developing lobar bronchi ( Fig. 4O ,P) and also in the tip of the developing lung bud (Fig. 4Q ,R). In addition to these sites, expression could also be seen in the mesothelial lining of the abdominal organs, the mesonephros and the medial nasal process (Fig. 4D ,E). At dE16.5, the most striking expression domain was developing skeletal muscle ( Fig. 5A ). All skeletal muscles throughout the body expressed high levels of Capn6 mRNA (see examples in Fig. 5B±G ). There was no expression in the developing bone as exempli®ed by the expression of Capn6 in the intercostal muscles of the developing vertebral column but its absence from the vertebral bodies themselves (Fig. 5F,G) .
Apart from the mesothelial lining, most internal organs were negative with the exception of the developing lung and kidney. In kidney, Capn6 mRNA was localized to the outermost cells which probably represent the capsule (Fig. 5J,K) . Similarly, the lung capsule was also positive although there appeared to be additional expression in trabeculae running off this capsule into the substance of the lung (Fig. 5F,G) .
Three weeks after birth, there was no detectable Capn6 mRNA by in situ hybridization in tongue, skeletal muscle or abdominal organs (data not shown). Thus Capn6 is strongly down-regulated sometime early during postnatal life.
There is a correlation in the spatial and temporal expression patterns of Capn3 and Capn6 during development, both being expressed predominantly in skeletal muscle (Fougerousse et al., 1998) . Furthermore, like Capn6, the human CAPN3 orthologue is expressed in the heart early in embryogenesis but later disappears. However, some differences do exist. While Capn6 activity is rapidly down-regulated after birth, Capn3 expression persists in skeletal muscle (Richard and Beckmann, 1996) . Furthermore, the lens, which is a major site of Capn3 mRNA (Ma et al., 1999) did not contain any detectable Capn6 mRNA (data not shown). As Capn6 lacks the conserved amino acids of the protease active site (Dear et al., 1997) it may act through a dominant-negative mechanism perhaps by interfering with the interaction of other calpains with partner proteins or by binding to calpain substrates thereby protecting them from cleavage by other calpains. The high correlation in spatial and temporal expression of these two mRNA warrants further investigation of the possibility that Capn6 could be an antagonist of Capn3 during embryogenesis. 
Expression of Capn11 mRNA
Capn11, like its human orthologue, was only expressed in testis. In situ hybridization of paraf®n sections of male and female embryos at various stages of development did not reveal any expression (data not shown). This suggested that Capn11 expression in the testis commenced postnatally.
Prepubertal mouse testis development is characterized by the synchronous maturation of the different cell types (Russell et al., 1990 ) which allows gene expression to be correlated with speci®c germ cell types by analyzing mouse testis RNA at various times after birth. High expression of Capn11 mRNA ®rst commenced between 14±18 days postnatally (Fig. 6A) . As pachytene spermatocytes ®rst appear on day 14 and secondary spermatocytes on day 18 of the ®rst cycle, with spermatogonia appearing earlier and spermatids later, this suggests that Capn11 mRNA is ®rst expressed in the spermatocytes.
The expression was further investigated by in situ hybridization to paraf®n sections of adult (8-week-old) mouse testis. A hall mark of spermatogenesis in the mouse is that the wave of spermatogenesis advances along the longitudinal axis of the seminiferous tubule. Thus each tubule crosssection contains a particular combination of cells corresponding to a distinct stage of spermatogenesis. In contrast, due to random localization of seminiferous tubules, the entire testis cross-section will contain cross-sections of tubules at all stages of spermatogenesis. The spermatogenic cycle is conveniently divided into 12 stages designated Stage I±XII (Russell et al., 1990) . Expression of Capn11 was restricted to the spermatocytes with no expression in the spermatogonia or the post-meiotic spermatids (Fig. 6B±  G) . Furthermore, expression was only observed in the spermatocytes of tubule cross-sections at the later stages of the cycle (approximately Stage V onwards) (Fig. 6C and data not shown). Spermatocytes in Stage V are in the mid-late pachytene stage of the ®rst meiotic division (Russell et al., 1990) . Therefore, Capn11 mRNA is restricted to a speci®c cell type, the spermatocyte, and to speci®c stages of its meiotic cycle, from mid-late pachytene of meiosis I through to meiosis II.
It is noteworthy that CAPN11 was previously localized to the short arm of chromosome 6 using radiation hybrid panel mapping . This is the site of the distal inversion of the t-complex (Silver, 1985) , a region within the MHC containing a cluster of genes that are expressed in the testis (Yeom et al., 1992) . Capn11 may belong to this cluster.
Experimental procedures

DNA and RNA probes
The Capn5, Capn6 and Capn7 cDNAs used as templates for synthesis of 32 P-DNA and 33 P-RNA probes used for northern and in situ hybridization corresponded to nucleotides 1529±2324, 1141±2016 and 1725±2536 of the published sequences (EMBL/GenBank Accession Nos. Y10656, Y12582, AJ012475.1), respectively. These probes were of a similar length, did not cross-hybridize with other known calpains and hybridized to a single RNA species on Northern blots. Moreover, Southern blots con®rm only one (H,I) . Abbreviations: d, diaphragm; h, heart; int, intestine; k, kidney; lu, lung; li, liver; t, tongue; vc, vertebral column. Scale bars, 1 mm (A±I), 100 mm (J).
gene hybridizes with each of these probes in the mouse genome (data not shown). The mouse Capn11 cDNA was obtained by screening of a Clontech mouse testis cDNA library according to the manufacturer's instructions. Sequence analysis con®rmed that the cDNA corresponded to the mouse orthologue. The CD3e and Whn RNA probes Russell et al. (1990) . Scale bar, 100 mm (B,C), 10 mm (F,G).
were synthesized from the cDNA-containing plasmids pDL1 (Clevers et al., 1988) and pAS21 (Nehls et al., 1994) , respectively.
RNA dot blot hybridization
The Mouse RNA master blot, a nylon membrane to which poly(A)
1 RNAs from various mouse tissues have been immobilized in separate dots was purchased from Clontech. 32 P-labeled probes were prepared by random priming (Feinberg and Vogelstein, 1983) . Hybridization was accomplished using Clontech Expresshyb hybridization solution according to the manufacturer's instructions. High-stringency washing was performed at 658C in 0:1£ SSC.
Whole-mount in situ hybridization
Sense and antisense dioxygenin-containing RNAs were prepared by in vitro transcription of plasmid DNAs in a reaction volume of 20 ml containing 1£transcription buffer (buffer provided by Stratagene for T7 and T3 RNA polymerases; Boehringer Mannheim for SP6 RNA polymerase), 2 ml DIG RNA labeling mix (Boehringer, Mannheim), 10 mM DTT, 1 mg linearized plasmid DNA, 40 units RNAsin (Promega) and 10 units RNA polymerase. After incubation for 2 h at 378C the template DNA was removed by addition of 2 units DNAaseI (Boehringer, Mannheim) followed by incubation at 378C for 30 min. The reactions was extracted with phenol-chloroform, ethanol precipitated and resuspended in 100 ml DEPC-treated dH 2 0. Embryo ®xation, in situ hybridization and staining for hybridized RNA was as previously described (Conlan and Rossant, 1992) .
In situ RNA hybridization to tissue sections
Embryos were ®xed in 4% (w/v) paraformaldehyde in PBS and 5 mm tissue sections were transferred to SuperFrost Plus (Menzel±Glaeser) precleaned slides. 33 P-labeled sense and antisense RNAs were synthesized as described above for whole mount in situs except that 40 mCi a-33 P-UTP and 200 mM ATP, CTP, GTP replaced the DIG RNA labeling mix. Hybridization of probes to tissue sections was as previously described (Dressler and Gruss, 1989 ) using a hybridization temperature of 558C.
RT-PCR
Total RNA was isolated from various prepubertal and adult testes as previously described (Chomczynski and Sacchi, 1987) . 5 mg total RNA was transcribed into cDNA using the Promega Reverse Transcription System according to the manufacturer's instructions. PCRs were performed in 50 ml reaction volumes containing 50 mM KCl, 10 mM Tris±HCl, pH 9, 1.5 mM MgCl 2 , 2 units Taq DNA polymerase (Fermentas) and 0.1 ng cDNA with a thermocycling protocol of 30 cycles of 30 s at 948C, 30 s at 588C and 1 min at 728C. The sequences of the mouse Capn11 primers used were: forward 5 H -AGCGGCCAAAGGATAT-3 H and reverse 5 H -ATCATCCTTCTTGTG-3 H .
Direct sequencing of PCR products
Following PCR, DNA products were excised from agarose TBE gels and puri®ed using Geneclean (Bio101, Vista, California) according to the manufacturer's instructions. Yields were quantitated by agarose gel electrophoresis alongside DNA standards of know concentrations. A 10 ml reaction mix containing 4 ml BigDye reaction mix (Perkin±Elmer Biosystems), 200 ng puri®ed DNA and 5 pmoles primer was incubated for 30 cycles of 948C, 15 s; 458C, 15 s; 608C,4 min. The reaction product was separated by polyacrylamide gel electrophoresis using an ABI 377 DNA sequencer and the sequence determined by analysis of dye terminator¯uorescence using the Perkin±Elmer Biosystems Sequence Analysis software version 3.3.
